F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatmentnews2023-03-16T21:15:49+00:00March 16th, 2023|The New York Times|
F.D.A. Approves New Nasal Spray for Migrainesnews2023-03-10T18:37:27+00:00March 10th, 2023|The New York Times|
FDA Panel Recommends 2 RSV Vaccines for Older Adultsnews2023-03-01T21:29:15+00:00March 1st, 2023|The New York Times|
China’s Abrupt Covid Pivot Leaves Many Without Medicinesnews2022-12-20T10:30:40+00:00December 20th, 2022|The New York Times|
New Booster Shot Targets Covid Variants More Effectively, Pfizer Saysnews2022-11-04T22:39:18+00:00November 4th, 2022|The New York Times|
Prosecute Trump, Despite the Risks?news2022-09-01T20:05:08+00:00September 1st, 2022|The New York Times|
Moderna Sues Pfizer and BioNTech Over Covid Vaccinenews2022-08-26T14:16:50+00:00August 26th, 2022|The New York Times|
Biden Administration Plans to Offer Updated Booster Shots in Septembernews2022-07-29T03:19:06+00:00July 29th, 2022|The New York Times|
What to Know About Covid Vaccine Doses for Very Young Childrennews2022-06-18T19:31:13+00:00June 18th, 2022|The New York Times|
What’s Next on Moderna and Pfizer Vaccines for Very Young Kids?news2022-06-15T22:12:20+00:00June 15th, 2022|The New York Times|
